Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05367544 · ClinicalTrials.gov registry record · NA

Equity in Prevention and Progression of Hypertension by Addressing Barriers to Nutrition and Physical activitY

A NA study of Hypertension and Blood Pressure, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
528
Enrollment target
1
Study location

NCT05367544 is a NA study of Hypertension and Blood Pressure that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 528 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05367544, a NA study of Hypertension and Blood Pressure, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
528 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to test an intervention to prevent high blood pressure among rural, Black adults living in Alabama. Black adults in this region have one of the highest rates of high blood pressure in the US. Eating fruits and vegetables and exercising daily lowers the chance of getting high blood pressure. Many problems get in the way of eating a healthy diet and exercising like a lack of grocery stores with fresh foods, few gyms, little money, lack of transportation, and limited support for keeping healthy habits. One place where many Black adults in rural Alabama meet weekly and feel supported is their church. The investigators will connect with 30 churches in rural Alabama. The investigators plan to hold health fairs to find 12 Black adults from each church with blood pressure that is higher than normal but not high enough to need blood pressure lowering medications. The investigators will randomly select 15 churches to get group health education and tablets to access online cooking shows and exercise classes. Adults in the other 15 churches will get support from a health coach over the telephone to help set and meet diet and physical activity goals as well as the group health education and tablets to access online cooking shows and exercise classes. In this study, the investigators will ask church members to sign up to be a health coach. These 15 churches will also get money to help bring healthy foods and/or physical activity opportunities to their communities. The investigative team will train 2 to 3 of their church members to learn how to coach others to eat more healthy food and be more physically active. This study answers two questions. 1) Will this intervention designed to reduce barriers to a healthy lifestyle lower blood pressure among rural, Black adults? 2) Can churches and participants complete the whole two-year study, and can the intervention be used in other communities in a cost-effective way to improve blood pressure? This project will

Interventions

  • BEHAVIORAL Health Education
  • BEHAVIORAL Individual-Level Peer Support
  • BEHAVIORAL Community-Level Peer Support

Study Locations (1)

Alabama

  • University of Alabama At Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 528 participants
Start Date 2022-08-13
Est. Completion 2026-09
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05367544

The ClinicalTrials.gov registry entry for NCT05367544 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 528 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (85% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Health Education is the first listed.

NCT05367544 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05367544 about?

NCT05367544 is a clinical study titled "Equity in Prevention and Progression of Hypertension by Addressing Barriers to Nutrition and Physical activitY". The goal of this study is to test an intervention to prevent high blood pressure among rural, Black adults living in Alabama. Black adults in this region have one of the highest rates of high blood pressure in the US. Eating fruits and vegetables and exercising daily lowers the chance of getting hig...

What is the current status of trial NCT05367544?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 528 participants. The study started on 2022-08-13. Estimated completion is 2026-09.

What conditions does trial NCT05367544 study?

This clinical trial studies the following conditions: Hypertension, Blood Pressure, Prehypertension.

What interventions are being tested in trial NCT05367544?

The interventions under investigation include: Health Education (BEHAVIORAL), Individual-Level Peer Support (BEHAVIORAL), Community-Level Peer Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT05367544?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05367544 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.